Date of Presentation

5-4-2023 12:00 AM

College

Rowan-Virtua School of Osteopathic Medicine

Poster Abstract

Xylazine, according to the National Institutes of Health (NIH), is a non-opioid tranquilizer used in veterinary medicine. Although this drug has not been approved for human use, it can be linked to an increase in opioid overdose deaths due to its role as an adulterant in drugs like fentanyl.

Xylazine was detected in drugs involved in 41% of all opioid-involved unintentional deaths and in 44% of all unintentional overdose deaths with fentanyl involved in the year of 2021 in Philadelphia.

Keywords

Xylazine, Fentanyl, Opioids, Drug Adulteration, Substance-Related Disorders

Disciplines

Community Health and Preventive Medicine | Health Services Research | Heterocyclic Compounds | Medicine and Health Sciences | Other Chemicals and Drugs | Pathological Conditions, Signs and Symptoms | Substance Abuse and Addiction

Document Type

Poster

Share

COinS
 
May 4th, 12:00 AM

Growing Use of Xylazine as an Adulterant in Opioids and Its Effects

Xylazine, according to the National Institutes of Health (NIH), is a non-opioid tranquilizer used in veterinary medicine. Although this drug has not been approved for human use, it can be linked to an increase in opioid overdose deaths due to its role as an adulterant in drugs like fentanyl.

Xylazine was detected in drugs involved in 41% of all opioid-involved unintentional deaths and in 44% of all unintentional overdose deaths with fentanyl involved in the year of 2021 in Philadelphia.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.